Coherus Oncology, Inc. SEC filings CHRS
Coherus Oncology, Inc. has 921 filings in SEC EDGAR's recent list, going back to Feb 23, 2011. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 5, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Apr 20, 2026 | Dec 31, 2025 |
| 10-K | Annual report | Mar 9, 2026 | Dec 31, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| 10-K | Annual report | Mar 17, 2025 | Dec 31, 2024 |
| ARS | Annual report to shareholders | Apr 15, 2024 | Dec 31, 2023 |
| 10-K | Annual report | Mar 15, 2024 | Dec 31, 2023 |
| ARS | Annual report to shareholders | Apr 17, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 6, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 23, 2022 | Dec 31, 2021 |
| 10-K | Annual report | Feb 25, 2021 | Dec 31, 2020 |
| 10-K | Annual report | Feb 27, 2020 | Dec 31, 2019 |
| 10-K | Annual report | Feb 28, 2019 | Dec 31, 2018 |
| 10-K | Annual report | Mar 8, 2018 | Dec 31, 2017 |
| 10-K | Annual report | Mar 14, 2017 | Dec 31, 2016 |
| 10-K | Annual report | Feb 29, 2016 | Dec 31, 2015 |
| 10-K | Annual report | Mar 23, 2015 | Dec 31, 2014 |
Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CHRS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Redwood City, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1512762
- Former names
- Coherus BioSciences, Inc. (until May 28, 2025); BioGenerics, Inc. (until Jan 3, 2012)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.